Pacira BioSciences (PCRX) EBT Margin Growth (3y) (2013 - 2026)
Pacira BioSciences (PCRX) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1,840.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -134.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1,686.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 12,811.00 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 5,487.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -225.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -15,283.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1,162.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 4,514.00 |
| 10 | Pacira BioSciences | 940.31 Mn | 738.13 Mn | 140.96 Mn | 1,933.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,933.00 |
| Dec 31, 2025 | -348.00 |
| Sep 30, 2025 | 407.00 |
| Jun 30, 2025 | -1,405.00 |
| Mar 31, 2025 | 54.00 |
| Dec 31, 2024 | 1,753.00 |
| Sep 30, 2024 | -10,134.00 |
| Jun 30, 2024 | 163.00 |
| Mar 31, 2024 | -253.00 |
| Dec 31, 2023 | 891.00 |
| Sep 30, 2023 | 489.00 |
| Jun 30, 2023 | 3,202.00 |
| Mar 31, 2023 | -2,461.00 |
| Dec 31, 2022 | 666.00 |
| Sep 30, 2022 | 679.00 |
| Jun 30, 2022 | 1,189.00 |
| Mar 31, 2022 | 737.00 |
| Dec 31, 2021 | -1,264.00 |
| Sep 30, 2021 | 1,981.00 |
| Jun 30, 2021 | 1,583.00 |